Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,052 | -11,697 | -7,819 | -3,656 | -16,656 |
| Depreciation Amortization | 388 | 292 | 194 | 96 | 2,074 |
| Accounts payable and accrued liabilities | 6 | -324 | 133 | -13 | 148 |
| Other Working Capital | -797 | -143 | -423 | -780 | 4,736 |
| Other Operating Activity | 1,260 | 1,367 | 613 | 444 | 3,573 |
| Operating Cash Flow | $-14,196 | $-10,506 | $-7,303 | $-3,909 | $-6,125 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -191 | -149 | -127 | -76 | -259 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1,000 |
| Investing Cash Flow | $-191 | $-149 | $-127 | $-76 | $741 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 650 |
| Debt Repayment | N/A | N/A | N/A | N/A | -100 |
| Common Stock Issued | 648 | 648 | N/A | N/A | 28,485 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -598 |
| Financing Cash Flow | $648 | $648 | $N/A | $N/A | $28,437 |
| Beginning Cash Position | 23,645 | 23,645 | 23,645 | 23,645 | 592 |
| End Cash Position | 9,906 | 13,637 | 16,215 | 19,660 | 23,645 |
| Net Cash Flow | $-13,738 | $-10,007 | $-7,430 | $-3,985 | $23,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,196 | -10,506 | -7,303 | -3,909 | -6,125 |
| Capital Expenditure | -191 | -149 | -127 | -76 | -259 |
| Free Cash Flow | -14,386 | -10,655 | -7,430 | -3,985 | -6,385 |